Scorpion Therapeutics: Funding, Investors & Team (Oct 2026)
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0, a pipeline of targeted small-molecule drugs that overcome the limitations of existing treatments. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology. For more information, visit scorpiontx.com.
Scorpion Therapeutics has raised $312M across 2 funding rounds on record, the most recent a Series C of $150M announced in Jul 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Scorpion Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2024.
Scorpion Therapeutics Funding Rounds
Scorpion Therapeutics raised $162M in a Series B announced in Jan 2021.
3.5 years later, a Series C of $150M was announced in Jul 2024.
Scorpion Therapeutics Founders and Leadership Team
Contact details for the Scorpion Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →Scorpion Therapeutics Funding Compared to Other Biotechnology Startups
Scorpion Therapeutics' latest round of $150M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Scorpion Therapeutics in Biotechnology and Boston
Companies Similar to Scorpion Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Scorpion Therapeutics Funding FAQs
What does Scorpion Therapeutics do?
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0, a pipeline of targeted small-molecule drugs that overcome the limitations of existing treatments. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology. For more information, visit scorpiontx.com.
How much funding has Scorpion Therapeutics raised?
Scorpion Therapeutics has raised $312M across 2 rounds on record. The most recent is a Series C of $150M announced in Jul 2024.
When did Scorpion Therapeutics last raise funding?
Scorpion Therapeutics' most recent funding round on record is a Series C of $150M, announced in Jul 2024.
Who founded Scorpion Therapeutics?
FundedIQ lists Axel Hoos (Founder) at Scorpion Therapeutics.
Who is the CEO of Scorpion Therapeutics?
Gary Glick is listed as CEO at Scorpion Therapeutics.
Where is Scorpion Therapeutics headquartered?
Scorpion Therapeutics is based in Boston, Massachusetts, United States.
How many employees does Scorpion Therapeutics have?
Scorpion Therapeutics is in the 101-250 employee band.
How does Scorpion Therapeutics' funding compare to other Biotechnology startups?
Scorpion Therapeutics' latest round of $150M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Scorpion Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Scorpion Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.